Patents Assigned to Mitsubishi-Kagaku Foods Corporation
-
Patent number: 9603827Abstract: Provided is a novel method for preventing and/or treating hairy wart disease which is a hoof and leg disease of ungulates. The method is carried out by administering an isothiocyanic acid ester such as allyl isothiocyanate to a hoof of an ungulate. Examples of ungulates targeted for application of the present invention include cows such as dairy cows as well as sheep, pigs and horses.Type: GrantFiled: December 30, 2015Date of Patent: March 28, 2017Assignees: MITSUBISHI-KAGAKU FOODS CORPORATION, INCORPORATED NATIONAL UNIVERSITY IWATE UNIVERSITYInventors: Keiji Okada, Yasushi Sekiyama
-
Publication number: 20160106701Abstract: Provided is a novel method for preventing and/or treating hairy wart disease which is a hoof and leg disease of ungulates. The method is carried out by administering an isothiocyanic acid ester such as allyl isothiocyanate to a hoof of an ungulate. Examples of ungulates targeted for application of the present invention include cows such as dairy cows as well as sheep, pigs and horses.Type: ApplicationFiled: December 30, 2015Publication date: April 21, 2016Applicants: Mitsubishi-Kagaku Foods Corporation, Incorporated National University Iwate UniversityInventors: Keiji OKADA, Yasushi SEKIYAMA
-
Publication number: 20130150456Abstract: To provide an antibacterial agent effective against gram-positive bacteria, particularly an antibacterial agent that is safe even when added to foods and the like, and a disinfecting method. An antibacterial agent comprising as an active ingredient either one or both of compounds represented by the following formula (1) and (2) contained in a labiatae plant extract: This antibacterial agent has antibacterial activity against gram-positive bacteria belonging to the genus Staphylococcus, the genus Lactobacillus, the genus Listeria, the genus Alicyclobacillus or the genus Bacillus.Type: ApplicationFiled: February 7, 2013Publication date: June 13, 2013Applicants: MITSUBISHI-KAGAKU FOODS CORPORATION, MITSUBISHI CHEMICAL CORPORATIONInventors: MITSUBISHI CHEMICAL CORPORATION, MITSUBISHI-KAGAKU FOODS CORPORATION
-
Patent number: 8389029Abstract: The object of the present invention is to provide a deterioration smell inhibitor capable of effectively inhibiting deterioration smell generating form various products such as foods and cosmetics. The present invention relates to a deterioration smell inhibitor comprising a plant extract and isothiocyanate. As preferred embodiments, the plant extract is a labiatae plant extract, further the labiatae plant extract is an oil-insoluble labiatae plant extract, still further the weight ratio of the oil-insoluble labiatae plant extract/isothiocyanate is 1/1 to 99/1. In other preferred embodiments, the plant extract is a terpenoid alcohol or terpenoid ketone, further the weight ratio of the terpenoid alcohol or terpenoid ketone/isothiocyanate is 0.4/1 to 40/1.Type: GrantFiled: July 11, 2012Date of Patent: March 5, 2013Assignees: Mitsubishi Chemical Corporation, Mitsubishi-Kagaku Foods CorporationInventors: Hirotsugu Kido, Shigeo Il
-
Patent number: 8338133Abstract: A glyceroglycolipid lipase which is highly safe, hydrolyzes a neutral fat, a glycerophospholipid or a glyceroglycolipid at about pH 6, is thermally stable, hydrolyzes lecithin, does not hydrolyze lysolecithin, can rise a bread when used singly in the production of the bread, and has no unpleasant odor. Specifically disclosed is a glyceroglycolipid lipase derived from a filamentous bacterium Aspergillus japonicus.Type: GrantFiled: January 30, 2008Date of Patent: December 25, 2012Assignee: Mitsubishi-Kagaku Foods CorporationInventors: Kaoru Tsukazaki, Tetsuya Fukazawa, Isshin Tanaka
-
Publication number: 20120276038Abstract: The object of the present invention is to provide a deterioration smell inhibitor capable of effectively inhibiting deterioration smell generating form various products such as foods and cosmetics. The present invention relates to a deterioration smell inhibitor comprising a plant extract and isothiocyanate. As preferred embodiments, the plant extract is a labiatae plant extract, further the labiatae plant extract is an oil-insoluble labiatae plant extract, still further the weight ratio of the oil-insoluble labiatae plant extract/isothiocyanate is 1/1 to 99/1. In other preferred embodiments, the plant extract is a terpenoid alcohol or terpenoid ketone, further the weight ratio of the terpenoid alcohol or terpenoid ketone/isothiocyanate is 0.4/1 to 40/1.Type: ApplicationFiled: July 11, 2012Publication date: November 1, 2012Applicants: MITSUBISHI-KAGAKU FOODS CORPORATION, MITSUBISHI CHEMICAL CORPORATIONInventors: Hirotsugu KIDO, Shigeo Il
-
Publication number: 20110293786Abstract: A phospholipase C enzyme having the ability to hydrolyze a phospholipid in both acidic and around neutral ranges and in a citrate buffer solution, as well as having a degree of heat stability, and having a property not to hydrolyze phosphate esters not containing lipid moieties. The phospholipase C enzyme shows activity from acidic to neutral pH and does not substantially hydrolyze any phosphate esters except for phospholipids.Type: ApplicationFiled: June 22, 2011Publication date: December 1, 2011Applicant: MITSUBISHI-KAGAKU FOODS CORPORATIONInventors: Eiko Nagasaki, Tetsuya Fukazawa, Yasunori Ono
-
Patent number: 7993874Abstract: The present invention provides a phospholipase C enzyme(s) having ability to hydrolyze phospholipid in both acidic and around neutral ranges and the activity in a citrate buffer solution as well as having some degree of heat stability, and having a property not to hydrolyze phosphate esters not containing lipid moieties. The phospholipase C enzyme(s) shows the activity at from acidic to neutral pH and does not substantially hydrolyze any phosphate esters except for phospholipids.Type: GrantFiled: March 10, 2006Date of Patent: August 9, 2011Assignee: Mitsubishi-Kagaku Foods CorporationInventors: Eiko Nagasaki, Tetsuya Fukazawa, Yasunori Ono
-
Publication number: 20110151034Abstract: To provide an antibacterial agent effective against gram-positive bacteria, particularly an antibacterial agent that is safe even when added to foods and the like, and a disinfecting method. An antibacterial agent comprising as an active ingredient either one or both of compounds represented by the following formula (1) and (2) contained in a labiatae plant extract: This antibacterial agent has antibacterial activity against gram-positive bacteria belonging to the genus Staphylococcus, the genus Lactobacillus, the genus Listeria, the genus Alicyclobacillus or the genus Bacillus.Type: ApplicationFiled: August 3, 2009Publication date: June 23, 2011Applicants: Mitsubishi Chemical Corporation, Mitsubishi-Kagaku Foods CorporationInventors: Hirotsugu Kido, Shigeo Ii
-
Patent number: 7923035Abstract: The humidity-dependent antibacterial powdery composition comprises a volatile oily antibacterial substance contained in a high ratio and a water-soluble film forming agent and the behavior of release of the antibacterial substance is changed depending on humidity. The process for producing the same is characterized in that a water-soluble film forming agent optionally together with a powder vehicle is dissolved and/or dispersed in water, subsequently a volatile oily antibacterial substance optionally together with an emulsifying agent is added to the solution and emulsified, and thereafter the obtained emulsion is spray dried into powder. The humidity-dependent antibacterial food storing article is characterized by carrying the humidity-dependent antibacterial powdery composition. The method of storing food is characterized in that the volatile oily antibacterial substance is released from the humidity-dependent antibacterial food storing article toward food lying in an atmosphere of 70% or higher humidity.Type: GrantFiled: October 22, 2003Date of Patent: April 12, 2011Assignee: Mitsubishi-Kagaku Foods CorporationInventors: Shigeo Ii, Asami Takata, Yuichi Mizukami, Ikuo Yashiki
-
Publication number: 20110009471Abstract: A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.Type: ApplicationFiled: July 22, 2010Publication date: January 13, 2011Applicants: DAIICHI SANKYO COMPANY, LIMITED, MITSUBISHI-KAGAKU FOODS CORPORATIONInventors: Masakatsu Kaneko, Koji Morita, Takeshi Imanishi
-
Patent number: 7816333Abstract: A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.Type: GrantFiled: July 27, 2007Date of Patent: October 19, 2010Assignees: Daiichi Sankyo Company, Limited, Mitsubishi-Kagaku Foods CorporationInventors: Masakatsu Kaneko, Koji Morita, Takeshi Imanishi
-
Publication number: 20090149404Abstract: A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.Type: ApplicationFiled: July 27, 2007Publication date: June 11, 2009Applicants: DAIICHI SANKYO COMPANY, LIMITED, MITSUBISHI-KAGAKU FOODS CORPORATIONInventors: Masakatsu Kaneko, Koji Morita, Takeshi Imanishi
-
Publication number: 20090053768Abstract: The present invention provides a phospholipase C enzyme(s) having ability to hydrolyze phospholipid in both acidic and around neutral ranges and the activity in a citrate buffer solution as well as having some degree of heat stability, and having a property not to hydrolyze phosphate esters not containing lipid moieties. The phospholipase C enzyme(s) shows the activity at from acidic to neutral pH and does not substantially hydrolyze any phosphate esters except for phospholipids.Type: ApplicationFiled: March 10, 2006Publication date: February 26, 2009Applicant: MITSUBISHI-KAGAKU FOOD CORPORATIONInventors: Eiko Nagasaki, Tetsuya Fukazawa, Yasunori Ono
-
Patent number: 7335765Abstract: A compound of the formula (1): wherein R1 and R2 are the same or different and represent a hydrogen atom, a hydroxyl protecting group, a phosphate group, or —P(R3)R4, wherein R3 and R4 are the same or different and represent a hydroxyl group, an amino group, an alkoxy group having from 1 to 4 carbon atoms, a cyanoalkoxy group having from 1 to 5 carbon atoms or an amino group substituted by an alkyl group having from 1 to 4 carbon atoms; A represents an alkylene group having from 1 to 4 carbon atoms and B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group or a substituted 2-oxo-pyrimidin-1-yl group having a substituent ? selected from the group consisting of a hydroxyl group which may be protected, an alkoxy group having from 1 to 4 carbon atoms, a mercapto group which may be protected, an alkylthio group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, an amino group which may be protected, a mono- or di-alkylamino group which may bType: GrantFiled: August 9, 2001Date of Patent: February 26, 2008Assignees: Daiichi Sankyo Company, Limited, Mitsubishi-Kagaku Foods CorporationInventors: Masakatsu Kaneko, Koji Morita, Takeshi Imanishi
-
Patent number: 7323203Abstract: The process for producing pickles of the invention comprises using an oil-in-water antimicrobial composition that contains allyisothiocyanate as the active ingredient and further contains surfactant and water added thereto, in any stage of producing pickles. The invention provides a process for stably producing pickles of good quality while taking suitable measures for surely suppressing the growth of microbes in producing pickles in a simplified manner. The antimicrobial composition of the invention comprises allyl isothiocyanate and a beta acids-containing hop extract as the active ingredients. This is useful as a food freshness-keeping agent free from all the problems with conventional AIT and hop extract each other.Type: GrantFiled: May 25, 2001Date of Patent: January 29, 2008Assignee: Mitsubishi-Kagaku Foods CorporationInventors: Shigeo Il, Asami Takata
-
Patent number: 7314923Abstract: A probe for a gene or a primer for starting amplification comprising an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of the nucleoside units is a structure of the formula (2): wherein A represents a C1-C4 alkylene group, and B is an unsubstituted purin-9-yl group, an unsubstituted 2-oxo-pyrimidin-1-yl-group, a substituted purin-9-yl-group or a substituted 2-oxo-pyrimidin-1-yl group. Also a method for preventing or treating a disease preventable or treatable by the antisense or antigene activity of an oligonucleotide by administering the oligonucleotide analogue.Type: GrantFiled: May 5, 2003Date of Patent: January 1, 2008Assignees: Daiichi Sankyo Company, Limited, Mitsubishi-Kagaku Foods CorporationInventors: Masakatsu Kaneko, Koji Morita, Takeshi Imanishi
-
Patent number: 5914149Abstract: A transparent liquid food of the present invention contains a sucrose fatty acid ester which has a constitutive fatty acid, which is a saturated or unsaturated fatty acid having 8 to 22 carbon atoms in aliphatic carbon chain thereof and having a monoester content of not less than 93% by weight, in which no cloudiness and precipitation in the transparent liquid foods, i. e., transparent beverages and foods arise when the sucrose fatty acid ester is added thereto.Type: GrantFiled: June 25, 1997Date of Patent: June 22, 1999Assignee: Mitsubishi-Kagaku Foods CorporationInventor: Masaaki Tomida